US2019002838A1PendingUtilityA1
Sindbis control virus
Est. expiryJun 19, 2035(~8.9 yrs left)· nominal 20-yr term from priority
C12N 2740/16031C12N 2740/16021C12N 2770/36143C12N 15/86C12N 2760/16022C12N 2740/16022C12N 7/00C12N 2770/36121C12N 2760/16031C12Q 1/70
35
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are compositions and methods related to replication deficient Sindbis viruses that are able to function as controls for nucleic acid diagnostic assays (e.g., nucleic acid sequencing based assays and/or nucleic acid amplification based assays).
Claims
exact text as granted — not AI-modified1 . A replication deficient recombinant Sindbis virus comprising a RNA genome comprising:
an open reading frame (ORF) encoding functional Sindbis non-structural proteins; and a heterologous RNA sequence.
2 . The replication deficient recombinant Sindbis virus of claim 1 , wherein the ORF encoding functional Sindbis non-structural proteins is located 5′ of the heterologous RNA sequence.
3 . The replication deficient recombinant Sindbis virus of claim 1 , wherein the ORF encoding Sindbis non-structural proteins has a nucleotide sequence that is at least 90% identical to nucleotides 1-7648 of SEQ ID NO: 1.
4 . (canceled)
5 . The replication deficient recombinant Sindbis virus of claim 1 , wherein the RNA genome lacks a sequence encoding a functional version of one or more of the Sindbis structural proteins.
6 .- 9 . (canceled)
10 . The replication deficient recombinant Sindbis virus of claim 1 , wherein the heterologous RNA sequence comprises a non-Sindbis RNA virus sequence or a retrovirus sequence.
11 .- 16 . (canceled)
17 . The replication deficient recombinant Sindbis virus of claim 10 , wherein the heterologous RNA sequence comprises a non-Sindbis RNA virus sequence.
18 . The replication deficient recombinant Sindbis virus of claim 17 , wherein the non-Sindbis RNA virus sequence is an Ebolavirus sequence, an influenza virus sequence, a SARS virus sequence, a hepatitis C virus sequence, a West Nile virus sequence, a Zika virus sequence, a poliovirus sequence, or a measles virus sequence.
19 . The replication deficient recombinant Sindbis virus of claim 18 , wherein the non-Sindbis RNA virus sequence is an Ebolavirus sequence.
20 .- 26 . (canceled)
27 . The replication deficient recombinant Sindbis virus of claim 10 , wherein the heterologous RNA sequence comprises a retrovirus sequence.
28 . The replication deficient recombinant Sindbis virus of claim 27 , wherein the retrovirus sequence is an HIV-1 sequence, an HIV-2 sequence, an HTLV-1 sequence, or an HTLV-II sequence.
29 . The replication deficient recombinant Sindbis virus of claim 28 , wherein the retrovirus sequence is an HIV-1 sequence.
30 .- 65 . (canceled)
66 . A composition, comprising a replication deficient Sindbis virus of claim 1 .
67 . The composition of claim 66 , wherein the replication deficient Sindbis virus comprising a RNA genome comprising a sequence that is at least 90% identical to SEQ ID NO: 11; and a replication deficient Sindbis virus comprising a RNA genome comprising a sequence that is at least 90% identical to SEQ ID NO: 13.
68 . (canceled)
69 . The composition of claim 66 , wherein the replication deficient Sindbis virus comprising a RNA genome comprising a sequence that is at least 90% identical to SEQ ID NO: 12; and a replication deficient Sindbis virus comprising a RNA genome comprising a sequence that is at least 90% identical to SEQ ID NO: 14.
70 . (canceled)
71 . The composition of claim 66 , wherein the replication deficient Sindbis virus comprising a RNA genome comprising a sequence that is at least 90% identical to either nucleotides 1-3446 of SEQ ID NO: 15, nucleotides 3294-5575 of SEQ ID NO: 15, nucleotides 5425-7722 of SEQ ID NO: 15, or nucleotides 7542-10272 of SEQ ID NO: 15.
72 .- 77 . (canceled)
78 . A nucleic acid molecule encoding the RNA genome of the replication deficient Sindbis virus of claim 1 .
79 . The nucleic acid molecule of claim 78 , wherein the nucleic acid molecule is an RNA molecule.
80 .- 82 . (canceled)
83 . A method of making a replication deficient Sindbis virus comprising:
(a) transfecting a cell with the RNA molecule of claim 79 encoding the RNA genome of the replication deficient Sindbis virus and a helper RNA molecule encoding functional Sindbis structural proteins; (b) culturing the transfected cell of step (a) under conditions such that the cell produces a replication deficient Sindbis virus comprising the mRNA genome; and (c) collecting the replication deficient Sindbis virus.
84 . (canceled)
85 . A method of testing a diagnostic assay, comprising performing the diagnostic assay on a composition of claim 66 .Join the waitlist — get patent alerts
Track US2019002838A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.